← Back to Patent Explorer
US4086221A Expired / Lapsed US ⏱️ 0.0 years remaining

Polypeptides and process for producing the same

Assignee: Asahi Kasei Corp
•
Filing: 1976-05-03
•
Granted: 1978-04-25
•
Expires: 1996-05-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Polypeptides of the formula <IMAGE> Gly-A10-A11-A12-Gln-A14-A15-A16-Lys-A18- A19-Thr-A21-Pro-A23-Thr-A25-A26-Gly-A28- Gly-A30-Pro-NH2 wherein A1 is Ser or Gly, A7 is Val or Met, A10 is Lys or Thr, A11 is Leu or Tyr, A12 is Ser or Thr, A14 is Glu or Asp, A15 is Leu or Phe, A16 is His or Asn, A18 is Leu or Phe, A19 is Gln or His, A21 is Tyr or Phe, A23 is Arg or Gln, A25 is Asp or Asn or Ala, A26 is Val or Thr or Ile, A28 is Ala or Ser or Val, and A30 is Thr or Val or Ala, and pharmaceutically acceptable acid addition salts and complexes, have serum calcium reducing activity.

Inventors

  • 👤 Shumpei Sakakibara
  • 👤 Tadanori Morikawa
  • 👤 Eisuke Munekata
  • 👤 Terutoshi Kimura
  • 👤 Yasuo Nakagawa
  • 👤 Toshiharu Noda

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 14:10
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/575; C07K14/585; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 44 words
A polypeptide selected from the group consisting of a compound of the formula ##STR17## wherein A 25 is Asp or Asn, A 26 is Val or Thr and A 28 is Ala or Ser, and a pharmaceutically acceptable acid addition salt or complex thereof.
Claim 2
Dependent Claim 44 words
A polypeptide selected from the group consisting of a compound of the formula ##STR17## wherein A 25 is Asp or Asn, A 26 is Val or Thr and A 28 is Ala or Ser, and a pharmaceutically acceptable acid addition salt or complex thereof.
Claim 3
Dependent Claim 6 words
A polypeptide of the formula ##STR18##
Claim 4
Dependent Claim 6 words
A polypeptide of the formula ##STR18##
Claim 5
Dependent Claim 6 words
A polypeptide of the formula ##STR19##
Claim 6
Dependent Claim 6 words
A polypeptide of the formula ##STR19##

References Cited (Backward Citations)

US3798203A Cited
US3891614A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-04-24 1981-10-24 1982-04-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-04-24 1985-10-24 1986-04-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-04-24 1989-10-24 1990-04-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag